Silandrone
Clinical data | |
---|---|
Routes of administration | Oral, intramuscular injection, subcutaneous injection |
Identifiers | |
| |
Synonyms | Testosterone 17β-trimethylsilyl ether; Testosterone O-trimethylsilyl ether; 17β-Trimethylsilyltestosterone; O-Trimethylsilyltestosterone; 17β-(trimethylsiloxy)androst-4-en-3-one; SC-16148; NSC-95147 |
CAS Number | 5055-42-5 |
PubChem (CID) | 68627 |
ChemSpider | 61886 |
UNII | YY7GL3CCE9 |
KEGG | D05837 |
ChEBI | CHEBI:607921 |
ChEMBL | CHEMBL485687 |
Chemical and physical data | |
Formula | C22H36O2Si |
Molar mass | 360.613 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Silandrone (INN, USAN) (developmental code names SC-16148, NSC-95147), also known as testosterone 17β-trimethylsilyl ether or 17β-trimethylsilyltestosterone, as well as 17β-(trimethylsiloxy)androst-4-en-3-one, is a synthetic anabolic-androgenic steroid (AAS) and an androgen ether – specifically, the 17β-trimethylsilyl ether of testosterone – which was developed by the G. D. Searle & Company in the 1960s but was never marketed.[1] It has a very long duration of action when given via subcutaneous or intramuscular injection as well as, notably, significantly greater potency than that of testosterone propionate.[2][3] In addition, it is notable that silandrone, unlike testosterone and most esters of testosterone like testosterone propionate, is orally active.[4]
See also
References
- ↑ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 642–. ISBN 978-1-4757-2085-3.
- ↑ Saunders FJ (November 1966). "A singularly long-acting ether of testosterone". Proc. Soc. Exp. Biol. Med. 123 (2): 303–4. doi:10.3181/00379727-123-31472. PMID 5951069.
- ↑ Le Boeuf BJ, Allen JL (1970). "Prolonged reinstatement of sexual behavior in castrated male rats with an ether of testosterone, SC-16148". Hormones and Behavior. 1 (2). doi:10.1016/0018-506X(70)90004-8.
- ↑ Leland J. Chinn (1969). The Chemistry and Biochemistry of Steroids. Geron-X. p. 97.